nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—CYP2D6—Hydroxyurea—head and neck cancer	0.4	0.739	CbGbCtD
Minaprine—CYP2D6—Vinblastine—head and neck cancer	0.142	0.261	CbGbCtD
Minaprine—Gefitinib—EGFR—head and neck cancer	0.0952	0.636	CrCbGaD
Minaprine—Gefitinib—CYP1A1—head and neck cancer	0.0545	0.364	CrCbGaD
Minaprine—HTR2A—GPCR downstream signaling—GRP—head and neck cancer	0.000598	0.00194	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—GRP—head and neck cancer	0.000595	0.00193	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000586	0.0019	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000574	0.00186	CbGpPWpGaD
Minaprine—ACHE—Metabolism—NAT2—head and neck cancer	0.000573	0.00186	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—UROD—head and neck cancer	0.000566	0.00184	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—TP53—head and neck cancer	0.000563	0.00183	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KISS1—head and neck cancer	0.000556	0.00181	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000552	0.00179	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—GRP—head and neck cancer	0.000552	0.00179	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00055	0.00178	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000546	0.00177	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000546	0.00177	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—GRP—head and neck cancer	0.000543	0.00176	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—GRP—head and neck cancer	0.000541	0.00175	CbGpPWpGaD
Minaprine—MAOA—Metabolism—NAT2—head and neck cancer	0.00054	0.00175	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—MAPK3—head and neck cancer	0.000537	0.00174	CbGpPWpGaD
Minaprine—HTR2B—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00053	0.00172	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000528	0.00171	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KISS1—head and neck cancer	0.000525	0.0017	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000511	0.00166	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—MAPK1—head and neck cancer	0.000511	0.00166	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—head and neck cancer	0.00051	0.00166	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—PTEN—head and neck cancer	0.000505	0.00164	CbGpPWpGaD
Minaprine—ACHE—Metabolism—DPYD—head and neck cancer	0.000502	0.00163	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—PTEN—head and neck cancer	0.000494	0.0016	CbGpPWpGaD
Minaprine—ACHE—Metabolism—YAP1—head and neck cancer	0.000477	0.00155	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000474	0.00154	CbGpPWpGaD
Minaprine—MAOA—Metabolism—DPYD—head and neck cancer	0.000473	0.00154	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000471	0.00153	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000463	0.0015	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GRP—head and neck cancer	0.000458	0.00149	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—TP53—head and neck cancer	0.000457	0.00148	CbGpPWpGaD
Minaprine—MAOA—Metabolism—YAP1—head and neck cancer	0.000449	0.00146	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—MAPK1—head and neck cancer	0.000449	0.00146	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KISS1—head and neck cancer	0.000449	0.00146	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT6—head and neck cancer	0.000445	0.00144	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000443	0.00144	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—head and neck cancer	0.000443	0.00144	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000441	0.00143	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000441	0.00143	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000439	0.00142	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GRP—head and neck cancer	0.000432	0.0014	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000431	0.0014	CbGpPWpGaD
Minaprine—HTR2C—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000428	0.00139	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—MAPK1—head and neck cancer	0.000423	0.00137	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT6—head and neck cancer	0.00042	0.00136	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000402	0.00131	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.0004	0.0013	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KISS1—head and neck cancer	0.000396	0.00129	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—YAP1—head and neck cancer	0.000394	0.00128	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KISS1—head and neck cancer	0.00039	0.00126	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KISS1—head and neck cancer	0.000388	0.00126	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000383	0.00124	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000383	0.00124	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000383	0.00124	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000381	0.00124	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000381	0.00124	CbGpPWpGaD
Minaprine—HTR2A—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000371	0.00121	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—YAP1—head and neck cancer	0.000371	0.0012	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GRP—head and neck cancer	0.00037	0.0012	CbGpPWpGaD
Minaprine—CHRM1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000369	0.0012	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—HRAS—head and neck cancer	0.000361	0.00117	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT6—head and neck cancer	0.000359	0.00116	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000358	0.00116	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000354	0.00115	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—TP53—head and neck cancer	0.000345	0.00112	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—HRAS—head and neck cancer	0.00034	0.0011	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—TP53—head and neck cancer	0.000337	0.00109	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000332	0.00108	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00033	0.00107	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GRP—head and neck cancer	0.000326	0.00106	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GRP—head and neck cancer	0.000321	0.00104	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GRP—head and neck cancer	0.000319	0.00104	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—YAP1—head and neck cancer	0.000318	0.00103	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT6—head and neck cancer	0.000317	0.00103	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000312	0.00101	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT6—head and neck cancer	0.000312	0.00101	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT6—head and neck cancer	0.00031	0.00101	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000307	0.000997	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000306	0.000992	CbGpPWpGaD
Minaprine—ACHE—Metabolism—TYMS—head and neck cancer	0.000286	0.000929	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSTM1—head and neck cancer	0.000283	0.000918	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—YAP1—head and neck cancer	0.00028	0.00091	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—YAP1—head and neck cancer	0.000276	0.000895	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—YAP1—head and neck cancer	0.000274	0.00089	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GPX1—head and neck cancer	0.000271	0.000879	CbGpPWpGaD
Minaprine—MAOA—Metabolism—TYMS—head and neck cancer	0.00027	0.000875	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYP1A1—head and neck cancer	0.000268	0.00087	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSTM1—head and neck cancer	0.000267	0.000865	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GPX1—head and neck cancer	0.000255	0.000828	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP1A1—head and neck cancer	0.000253	0.00082	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NAT2—head and neck cancer	0.000235	0.000763	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—IL2—head and neck cancer	0.000228	0.000739	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.00022	0.000715	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—IL2—head and neck cancer	0.000215	0.000697	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL2—head and neck cancer	0.000207	0.000671	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—DPYD—head and neck cancer	0.000206	0.000669	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—YAP1—head and neck cancer	0.000196	0.000635	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL2—head and neck cancer	0.000195	0.000633	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—IL2—head and neck cancer	0.000184	0.000596	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NOTCH1—head and neck cancer	0.000177	0.000576	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NOTCH1—head and neck cancer	0.000167	0.000543	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL2—head and neck cancer	0.000167	0.000541	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—MAPK3—head and neck cancer	0.000166	0.000539	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—IL2—head and neck cancer	0.000162	0.000526	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTGS2—head and neck cancer	0.00016	0.000518	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—IL2—head and neck cancer	0.000159	0.000517	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—IL2—head and neck cancer	0.000159	0.000515	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	0.000158	0.000513	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	0.000158	0.000513	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—MAPK3—head and neck cancer	0.000157	0.000509	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000151	0.00049	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTGS2—head and neck cancer	0.00015	0.000488	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—MAPK1—head and neck cancer	0.000149	0.000484	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—EGFR—head and neck cancer	0.000149	0.000484	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL2—head and neck cancer	0.000147	0.000478	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL2—head and neck cancer	0.000145	0.00047	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL2—head and neck cancer	0.000144	0.000467	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOTCH1—head and neck cancer	0.000143	0.000465	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000142	0.000462	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTEN—head and neck cancer	0.000139	0.000451	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	0.000137	0.000445	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	0.000134	0.000435	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTEN—head and neck cancer	0.000131	0.000425	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—PIK3CA—head and neck cancer	0.000129	0.00042	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	0.000128	0.000414	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	0.000128	0.000414	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	0.000127	0.000412	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	0.000126	0.00041	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	0.000124	0.000403	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOTCH1—head and neck cancer	0.000124	0.000401	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	0.000123	0.000401	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL2—head and neck cancer	0.000122	0.000396	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000122	0.000396	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HRAS—head and neck cancer	0.00012	0.000388	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCND1—head and neck cancer	0.000119	0.000386	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	0.000118	0.000384	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TYMS—head and neck cancer	0.000117	0.000381	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	0.000116	0.000378	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—head and neck cancer	0.000116	0.000378	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTM1—head and neck cancer	0.000116	0.000377	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MAPK3—head and neck cancer	0.000116	0.000376	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL2—head and neck cancer	0.000115	0.000374	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTEN—head and neck cancer	0.000115	0.000373	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	0.000113	0.000365	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	0.000113	0.000365	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCND1—head and neck cancer	0.000112	0.000364	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	0.000112	0.000364	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GPX1—head and neck cancer	0.000111	0.000361	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	0.000111	0.000359	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	0.000111	0.000359	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	0.000111	0.000359	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MAPK1—head and neck cancer	0.00011	0.000358	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—head and neck cancer	0.00011	0.000357	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	0.00011	0.000357	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTEN—head and neck cancer	0.000108	0.000352	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000108	0.000349	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000106	0.000343	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—head and neck cancer	0.000106	0.000343	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000105	0.000342	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	0.000104	0.000337	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT3—head and neck cancer	0.000103	0.000333	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	0.000102	0.000332	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	9.96e-05	0.000323	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL2—head and neck cancer	9.85e-05	0.00032	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	9.82e-05	0.000319	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3CA—head and neck cancer	9.82e-05	0.000318	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—head and neck cancer	9.79e-05	0.000318	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	9.77e-05	0.000317	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT3—head and neck cancer	9.69e-05	0.000314	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	9.61e-05	0.000312	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	9.6e-05	0.000312	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CA—head and neck cancer	9.56e-05	0.00031	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	9.34e-05	0.000303	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—head and neck cancer	9.34e-05	0.000303	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	9.27e-05	0.000301	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK3—head and neck cancer	9.26e-05	0.0003	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CA—head and neck cancer	9.25e-05	0.0003	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	9.04e-05	0.000293	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	9.04e-05	0.000293	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	8.89e-05	0.000289	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	8.85e-05	0.000287	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK1—head and neck cancer	8.81e-05	0.000286	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—head and neck cancer	8.81e-05	0.000286	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	8.79e-05	0.000285	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL2—head and neck cancer	8.69e-05	0.000282	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	8.65e-05	0.000281	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	8.6e-05	0.000279	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL2—head and neck cancer	8.55e-05	0.000278	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL2—head and neck cancer	8.51e-05	0.000276	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCND1—head and neck cancer	8.48e-05	0.000275	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	8.37e-05	0.000272	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	8.34e-05	0.000271	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCND1—head and neck cancer	8.29e-05	0.000269	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	8.29e-05	0.000269	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTEN—head and neck cancer	8.18e-05	0.000265	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	8.11e-05	0.000263	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	8.05e-05	0.000261	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—head and neck cancer	8.02e-05	0.00026	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTEN—head and neck cancer	8.01e-05	0.00026	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	7.98e-05	0.000259	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	7.92e-05	0.000257	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	7.85e-05	0.000255	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—head and neck cancer	7.84e-05	0.000254	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	7.81e-05	0.000253	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	7.64e-05	0.000248	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—head and neck cancer	7.55e-05	0.000245	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	7.54e-05	0.000245	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	7.53e-05	0.000244	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HRAS—head and neck cancer	7.5e-05	0.000243	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—head and neck cancer	7.39e-05	0.00024	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	7.39e-05	0.00024	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT3—head and neck cancer	7.32e-05	0.000237	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	7.27e-05	0.000236	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	7.23e-05	0.000235	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	7.2e-05	0.000234	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT3—head and neck cancer	7.16e-05	0.000232	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HRAS—head and neck cancer	7.07e-05	0.000229	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	6.99e-05	0.000227	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	6.88e-05	0.000223	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	6.84e-05	0.000222	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	6.65e-05	0.000216	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—head and neck cancer	6.65e-05	0.000216	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—head and neck cancer	6.62e-05	0.000215	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	6.54e-05	0.000212	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—head and neck cancer	6.54e-05	0.000212	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	6.54e-05	0.000212	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	6.54e-05	0.000212	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	6.51e-05	0.000211	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—head and neck cancer	6.51e-05	0.000211	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—head and neck cancer	6.33e-05	0.000205	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—head and neck cancer	6.24e-05	0.000203	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	6.05e-05	0.000196	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	5.77e-05	0.000187	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTEN—head and neck cancer	5.71e-05	0.000185	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	5.68e-05	0.000184	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	5.65e-05	0.000183	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—head and neck cancer	5.58e-05	0.000181	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—head and neck cancer	5.49e-05	0.000178	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—head and neck cancer	5.46e-05	0.000177	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	5.34e-05	0.000173	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HRAS—head and neck cancer	5.34e-05	0.000173	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	5.25e-05	0.00017	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HRAS—head and neck cancer	5.23e-05	0.00017	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—head and neck cancer	4.71e-05	0.000153	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	4.64e-05	0.000151	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—head and neck cancer	4.61e-05	0.00015	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	4.03e-05	0.000131	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—head and neck cancer	3.29e-05	0.000107	CbGpPWpGaD
